About Bioskryb
Bioskryb is a company based in Durham (United States) founded in 2018 by Jay West and Charles Gawad. Bioskryb has raised $11.5 million across 1 funding round from investors including Wilson Sonsini Goodrich & Rosati and Anzu Partners. The company has 21 employees as of December 31, 2021. Bioskryb offers products and services including ResolveOME, BaseJumper, and ResolveDNA. Bioskryb operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
- Headquarter Durham, United States
- Employees 21 as on 31 Dec, 2021
- Founders Jay West, Charles Gawad
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioskryb Genomics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.5 M (USD)
in 1 rounds
-
Latest Funding Round
$11.5 M (USD), Seed
Jan 09, 2020
-
Investors
Wilson Sonsini Goodrich & Rosati
& 1 more
-
Employee Count
21
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioskryb
Bioskryb offers a comprehensive portfolio of products and services, including ResolveOME, BaseJumper, and ResolveDNA.
Amplifies genome and transcriptome from single cells for integrated analysis.
Visualizes single-cell genomics data for molecular discovery insights.
Enables high genome recovery and variant detection in single-cell research.
People of Bioskryb
Unlock access to complete
Unlock access to complete
Funding Insights of Bioskryb
Bioskryb has successfully raised a total of $11.5M through 1 strategic funding round. The most recent funding activity was a Seed round of $11.5 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bioskryb
Bioskryb has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Wilson Sonsini Goodrich & Rosati and Anzu Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in industrial and life sciences technology companies.
|
Locked | Locked | Locked | |
|
Provider of legal services to technology and life science companies
|
Locked | Locked | Locked |
Investor details for Bioskryb
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioskryb
Investment portfolio details for Bioskryb
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioskryb
Detailed financials for Bioskryb
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioskryb Comparisons
Peer comparison for Bioskryb
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioskryb
Bioskryb operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| Locked | Locked | Locked |
Provider of genome analysis solutions to researchers and clinicians
|
Detailed competitors of Bioskryb
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioskryb
Complete news archive for Bioskryb
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioskryb
Bioskryb was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Bioskryb is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Jay West is the current CEO of Bioskryb. They have also founded this company.
Bioskryb is a funded company, having raised a total of $11.5M across 1 funding round to date.
As of Dec 31, 2021, the latest employee count at Bioskryb is 21.
BioSkryb has developed a genome amplification system for cellular heterogeneity. The SkrybAmp technology performs Primary Template Directed Amplification (PTA) is used for base calling DNA sequencing. The features of the technology are it can control the amplicon size for adding Barcode identifiers to detect DNA lesions. The technology is applied in ancestry genotyping, gene editing accuracy determination, and detection of single resistant mutant cells (MRD) in cancers.
Bioskryb offers ResolveOME, BaseJumper, and ResolveDNA.
Bioskryb has 2 investors. Key investors include Wilson Sonsini Goodrich & Rosati, and Anzu Partners.